LakeShore Biopharma Adopts Amended Share Incentive Plan
Ticker: LSBWF · Form: 6-K · Filed: Mar 12, 2025 · CIK: 1946399
| Field | Detail |
|---|---|
| Company | Lakeshore Biopharma CO., LTD. (LSBWF) |
| Form Type | 6-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-incentive, corporate-action, share-plan
TL;DR
LAKESHORE BIOPHARMA just updated its stock incentive plan to keep employees happy. Good for retention.
AI Summary
LakeShore Biopharma Co., Ltd. announced on March 12, 2025, the adoption of an Amended and Restated 2024 Share Incentive Plan. This plan aims to incentivize employees, directors, and consultants by allowing the company to grant awards such as share options, restricted shares, and other equity-based incentives.
Why It Matters
The adoption of an amended share incentive plan is a common corporate action to retain and motivate key personnel, which can impact future company performance and shareholder value.
Risk Assessment
Risk Level: low — This filing is a routine corporate update regarding an employee incentive plan and does not present immediate financial or operational risks.
Key Players & Entities
- LakeShore Biopharma Co., Ltd. (company) — Filer and subject of the report
- 2024 Share Incentive Plan (plan) — The subject of the amendment
FAQ
What is the purpose of the Amended and Restated 2024 Share Incentive Plan?
The plan is designed to provide incentives to employees, directors, and consultants of the Company through the granting of awards such as share options, restricted shares, and other equity-based incentives.
When was the Amended and Restated 2024 Share Incentive Plan adopted?
The plan was adopted by LakeShore Biopharma Co., Ltd. as of March 12, 2025.
What types of awards can be granted under the new plan?
The plan allows for the granting of awards such as share options, restricted shares, and other equity-based incentives.
Who is eligible to receive awards under the plan?
Employees, directors, and consultants of LakeShore Biopharma Co., Ltd. are eligible to receive awards under the plan.
What was the company's former name?
The company was formerly known as YS Biopharma Co., Ltd. and YishengBio Co., Ltd.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 12, 2025 regarding LakeShore Biopharma Co., Ltd. (LSBWF).